Invention Grant
![Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors](/docs/US/2013-03-19/US08399452B2/abs.jpg.600x600.jpg)
- Patent Title: Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors
-
Application No.: US11925151Application Date: 2007-10-26
-
Publication No.: US08399452B2Publication Date: 2013-03-19
- Inventor: Robert Déziel , Silvana Leit , Patrick Beaulieu , Yves Andre Chantigny , John Mancuso , Pierre Tessier , Gideon Shapiro , Richard Chesworth , David Smil
- Applicant: Robert Déziel , Silvana Leit , Patrick Beaulieu , Yves Andre Chantigny , John Mancuso , Pierre Tessier , Gideon Shapiro , Richard Chesworth , David Smil
- Applicant Address: CA Montreal US MA Watertown
- Assignee: Methylgene Inc.,EnVivo Pharmaceuticals
- Current Assignee: Methylgene Inc.,EnVivo Pharmaceuticals
- Current Assignee Address: CA Montreal US MA Watertown
- Agency: Fish & Richardson P.C.
- Main IPC: A61K31/553
- IPC: A61K31/553 ; A61K31/554 ; C07D267/16
![Dibenzo[b,f][1,4]oxazepin-11-yl-N-hydroxybenzamides as HDAC inhibitors](/abs-image/US/2013/03/19/US08399452B2/abs.jpg.150x150.jpg)
Abstract:
This invention relates to compounds for the inhibition of histone deacetylase. More particularly, the invention provides for compounds of formula (I) wherein Q, J, L and Z are as defined in the specification.
Public/Granted literature
- US20080207590A1 Inhibitors of Histone Deacetylase Public/Granted day:2008-08-28
Information query
IPC分类:
